Aida Pharmaceuticals (AIDA) 8-K Departure of Directors or Principal Officers

Exhibit 3.1

AMENDED ARTICLES OF INCORPORATION

OF

BAS CONSULTING, INC.

Pursuant to NRS 78.385 and 78.390 of the Nevada Business Corporations Act, BAS Consulting, Inc., (the "Corporation") adopts the following Amendment and Restatement of its Articles of Incorporation by stating the following:

FIRST:	The name of the Corporation shall be AIDA PHARMACEUTICALS, INC.
SECOND:	The following amendment and restatement to its Articles of Incorporation were adopted by    majority vote of shareholders of the Corporation on January 9, 2006 in the manner prescribed by  Nevada law.
THIRD:	The number of shares of the Corporation outstanding and entitled to vote at the time of the  adoption of said amendment was 25,000,000.
FOURTH:	The number of shares voted for such amendment and restatement was 20,570,000 or 82.28% and  the number voted against such amendment was 0 or 0%.
DATED:	January 9, 2006

 BAS CONSULTING, INC.

 /s/ Biao Jin

 Biao Jin

 Chief Executive Officer